Dr Elena Crisà/touchhaematology.com
Oct 19, 2025, 11:27
Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
TMC (Touch Medical Communications) shared a post on LinkedIn:
“Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
In this inspiring interview, Dr Elena Crisà (Candiolo Cancer Institute, Italy) discusses how precision medicine is transforming the diagnosis and treatment of acute myeloid leukaemia ( AML ).
From clinical trials to patient-centred care, Dr Crisà shares what drives her work and why aligning treatment with individual values is essential.”
Read the full feature here.
Stay updated with Hemostasis Today.
-
Feb 24, 2026, 14:31Augustina Isioma Ikusemoro: What Happens After You Donate Blood?
-
Feb 24, 2026, 14:27Eloïse Laouenan: Rising Risk of Pregnancy Related Venous Thromboembolism
-
Feb 24, 2026, 14:01A European Action Plan on Rare Diseases Is a Necessity, Not an Option – EPODIN
-
Feb 24, 2026, 13:59Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
-
Feb 24, 2026, 13:29Win Ratio Analysis of Edoxaban vs Dalteparin in Cancer-Associated VTE – JTH
-
Feb 24, 2026, 13:28EAHAD Welcomes New Members to the Nurses Committee
-
Feb 24, 2026, 13:25AbQader Bedil: Donor Ferritin Testing and Iron Care
-
Feb 24, 2026, 12:53Tagreed Alkaltham։ Blood Is a Naturally Integrated and Adaptive Physiological System
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH